Home The Word Brain My Amedeo FAQ Privacy About   


C49 + CC Journal Club

For more information, please refer to our special emails from April 13 and May 19.

  Hypertension

  Free Subscription


14.04.2025

2 Am Heart J
1 Am J Epidemiol
2 Am J Hypertens
1 Circulation
6 Eur Heart J
1 Eur J Pharmacol
3 Hypertension
1 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Hum Hypertens
3 J Hypertens
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. LIYANAGE-DON N, Phillips E, Schwartz JE, Chang MJ, et al
    Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network: Rationale and Design of the Monitor-BP Cluster Randomized Trial.
    Am Heart J. 2025 Apr 8:S0002-8703(25)00122-X. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available

  2. ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al
    Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension.
    Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available


    Am J Epidemiol

  3. PALOMAR-CROS A, Espinosa A, Bara S, Sanchez A, et al
    Outdoor artificial light-at-night and cardiometabolic disease risk: an urban perspective from the Catalan GCAT cohort study.
    Am J Epidemiol. 2025;194:963-974.
    PubMed         Abstract available


    Am J Hypertens

  4. TOMODA F, Koike T, Kurosaki H, Sugimori H, et al
    Impact of mild renal impairment on the relationship between blood pressure and renal fractional excretion of albumin in primary hypertension.
    Am J Hypertens. 2025 Apr 9:hpaf037. doi: 10.1093.
    PubMed         Abstract available

  5. ZAPATA RD, Tolani T, Reich R, Beneteau S, et al
    AI in Hypertensive Disorders of Pregnancy: Review.
    Am J Hypertens. 2025 Apr 9:hpaf052. doi: 10.1093.
    PubMed         Abstract available


    Circulation

  6. HONG J, Medzikovic L, Sun W, Wong B, et al
    Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2025;151:e921.
    PubMed        


    Eur Heart J

  7. WANG YL, Zhu H, Pan YT, Shang D, et al
    Dendritic cell mineralocorticoid receptor controls blood pressure by regulating T helper 17 differentiation: role of the Plcbeta1/4-Stat5-NF-kappaB pathway.
    Eur Heart J. 2025;46:1335-1351.
    PubMed         Abstract available

  8. SHARASHOVA E, Gerdts E, Ball J, Schnabel RB, et al
    Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromso Study.
    Eur Heart J. 2025 Jan 17:ehaf005. doi: 10.1093.
    PubMed         Abstract available

  9. CREA F
    Focus on blood pressure: sex-specific association with atrial fibrillation, role of gliflozins in hypertension, and new therapeutic targets in hypertension and orthostatic hypotension.
    Eur Heart J. 2025;46:1277-1280.
    PubMed        

  10. FAUVEL C, Lamblin N
    Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of << hasard >>.
    Eur Heart J. 2025 Apr 8:ehae814. doi: 10.1093.
    PubMed        

  11. XIONG G
    Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research.
    Eur Heart J. 2025 Apr 8:ehae812. doi: 10.1093.
    PubMed        

  12. KOBAYASHI M, Pitt B, Ferreira JP, Rossignol P, et al
    Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease.
    Eur Heart J. 2025 Apr 11:ehaf225. doi: 10.1093.
    PubMed         Abstract available


    Eur J Pharmacol

  13. WANG Y, Zhang Y, An X, Jiang Y, et al
    New LFA-1 inhibitor Orientin reduces angiotensin II-induced vascular remodeling.
    Eur J Pharmacol. 2025;995:177426.
    PubMed         Abstract available


    Hypertension

  14. LIU J, Li Y, Asayama K, Zhang XJ, et al
    Asian Expert Consensus on Nocturnal Hypertension Management.
    Hypertension. 2025 Apr 11. doi: 10.1161/HYPERTENSIONAHA.124.24026.
    PubMed         Abstract available

  15. LV W, Gu X, Zeng L, Liu K, et al
    Endothelial SMAD4 Deficiency Promotes Pulmonary Hypertension by Impairing Cell Adhesion and Extracellular Matrix Organization.
    Hypertension. 2025 Apr 11. doi: 10.1161/HYPERTENSIONAHA.124.22782.
    PubMed         Abstract available

  16. DOYON A, Bayazit AK, Duzova A, Thurn D, et al
    Hypertension Management Dynamics in Pediatric CKD: Insights From the 4C Study.
    Hypertension. 2025 Apr 8. doi: 10.1161/HYPERTENSIONAHA.124.24330.
    PubMed         Abstract available


    J Am Coll Cardiol

  17. MATHEW V, Khan RR, Jowell AR, Yan Q, et al
    Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women.
    J Am Coll Cardiol. 2025;85:1488-1500.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  18. PEDDI AN, Wheeler SE, Akkisetty K, Bucheit JD, et al
    Aprocitentan for Treatment-Resistant Hypertension: Pharmacology Concepts and Clinical Insights.
    J Cardiovasc Pharmacol. 2025 Apr 11. doi: 10.1097/FJC.0000000000001700.
    PubMed         Abstract available


    J Hum Hypertens

  19. SECKIN O, Unlu S, Yalcin MR
    The hidden role of left atrial strain: insights into end-organ damage in dipper and nondipper hypertension.
    J Hum Hypertens. 2025 Apr 12. doi: 10.1038/s41371-025-01017.
    PubMed         Abstract available


    J Hypertens

  20. JAIN A
    A young woman with severe renovascular hypertension due to essential thrombocytosis: case report and literature review.
    J Hypertens. 2025 Apr 8. doi: 10.1097/HJH.0000000000004031.
    PubMed         Abstract available

  21. RENNA NF, Ramirez EI, Vissani S, Farez BG, et al
    Optimizing hypertension management: the impact of drug class, socioeconomic factors, and simplified regimens on medication adherence. VATAHTA study.
    J Hypertens. 2025 Apr 7. doi: 10.1097/HJH.0000000000004023.
    PubMed         Abstract available

  22. HUTTL M, Miklovic M, Gawrys O, Molnar M, et al
    The treatment with soluble guanylate cyclase stimulator BAY41-8543 prevents malignant hypertension and associated organ damage.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004009.
    PubMed         Abstract available


    PLoS One

  23. HUNSDIECK B, Mielke J, Ickstadt K, Elci E, et al
    A simulation-based framework for modeling and prediction of personalized blood pressure trajectories in hypertensive patients after antihypertensive treatment.
    PLoS One. 2025;20:e0318549.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.